IL6 and classic Hodgkin lymphoma: In the 38 patients followed longitudinally, IL10, IL6 and BAFF serum levels decreased during the 24 months following cHL diagnosis (p < 0.0001, p = 0.02 and p < 0.0001), respectively (Table 4 and Figure 1).